Endothelial Dysfunction Occurs prior to Clinical Evidence of Polycystic Kidney Disease
Author(s) -
Karen M. Peterson,
Federico Franchi,
Darrel L. Loeffler,
Peter J. Psaltis,
Peter C. Harris,
Lilach O. Lerman,
Amir Lerman,
Martin RodriguezPorcel
Publication year - 2013
Publication title -
american journal of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.394
H-Index - 85
eISSN - 1421-9670
pISSN - 0250-8095
DOI - 10.1159/000354236
Subject(s) - medicine , endothelial dysfunction , enos , polycystic kidney disease , endocrinology , autosomal recessive polycystic kidney disease , endothelium , kidney disease , renal function , kidney , nitric oxide synthase , nitric oxide
Polycystic kidney disease (PKD), a monogenic disease with an autosomal dominant or an autosomal recessive form of inheritance (ARPKD), is the most common genetic cause of renal dysfunction and end-stage renal failure. In addition to the development of cysts, the autosomal form of PKD is associated with vascular endothelial dysfunction, a marker of vascular disease. Whether vascular endothelial dysfunction is also present in ARPKD, and its relationship with renal dysfunction remain to be determined.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom